Medium Risk

Vijaya Diagnostic Centre Limited

Activities of Independent Diagnostics/Pathological Laboratories

CIN: L85195TG2002PLC039075 FY: - Revenue: ₹627.1 Cr
5.3
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.0
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
5.0

Financial Exposure

Est. Compliance Cost₹1–4 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated79.6 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyUnknown
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.3
Impact Materiality4.6
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.1%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

**Vijaya Diagnostic Centre Limited – Financial Risk Summary** The company faces critical compliance exposure exceeding ₹1–4 crore annually, driven by uncertain Extended Producer Responsibility (EPR) applicability and incomplete greenhouse gas emissions reporting under SEBI BRSR mandates—non-compliance risks delisting and enforcement action for listed entities. With a maximum compliance risk score of 10.0/10, Vijaya must immediately clarify EPR obligations for biomedical waste management and establish Scope 1–2 emissions baselines; absence of reported emissions data suggests inadequate environmental accounting infrastructure. The 6.5/10 EPR exposure combined with sector-wide BRSR P6 environmental disclosure requirements creates operational cost uncertainty, particularly if biomedical waste streams trigger EPR compliance or if future carbon pricing at ₹600–900/tonne CO2e applies to diagnostic facility operations. Immediate priority: conduct regulatory gap assessment, quantify waste streams, and establish verified emissions tracking to mitigate delisting risk and ₹1–4 crore cost materialization.

Source: Vijaya Diagnostic Centre Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →